| Name | Title | Contact Details |
|---|
ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. ImpediMed`s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in breast cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm in female breast cancer patients.
20/20 Imaging is a Crystal Lake, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Masel Enterprise is a Bristol, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Interventional is a Campbell Hall, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
FusionOne is a Roselle, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.